Delivery Order SPE2DB20D3103-SPE2DB25FP5B9
Award Date 7/15/25
Potential Completion Date 7/16/25
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DEXCOM G7 SENSORS. The contract has a ceiling value of $1,499.54 and an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,082.76 contract is for the delivery of DEXCOM G7 SENSORS, a type of medical device, with a completion date of April 9, 2025. The contract does not have a set-aside designation, indicating it was open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DEXCOM G7 SENSORS, a type of medical device, with a ceiling value of $1,619.91 and a period of performance through May 14, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,031.20, is for the provision of DEXCOM G7 Sensors, a medical device used for diabetes management. The contract has an ultimate completion date of February 4, 2025 and a Firm Fixed Price pricing type. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of DEXCOM G7 SENSORS. The fixed-price contract has a ceiling value of $1,675.70 and a performance period extending through April 2025. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device used to monitor glucose levels. The contract has a firm fixed price of $1,031.20 and a performance period ending on July 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device, with a ceiling value of $2,702.66 and a period of performance through June 24, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and no major...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device, with a ceiling value of $3,213.11 and a performance period ending on July 9, 2025. The contract is a firm fixed-price delivery order, which means the price is set and not subject to adjustment. Amerisourcebergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS 1S, a medical device, with a ceiling value of $3,598.78 and an ultimate completion date of July 22, 2025. The contract is a firm fixed-price delivery order and is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device product, with a ceiling value of $5,739.49. The contract is a firm fixed price, non-set-aside award with a completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP5B9Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of DEXCOM G7 SENSORS, a medical device. The contract has a firm fixed price of $2,428.60 and a completion date of July 16, 2025. This order is not set aside and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to the DLA, Defense Health Agency, U.S. Coast Guard, and other government agencies through December 2026.
Generated 10/14/25, 10:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/15/25 |